SCHEMBL5161995

SCHEMBL5161995

Cc1nc(NCCc2ccccc2)sc1-c1ccnc(Nc2ccc(N3CCN(CC=O)CC3)cc2)n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.69
CDK9 P50750 14/20 0.58
AURKA O14965 11/20 0.58
AURKB Q96GD4 11/20 0.58
CDK7 P50613 7/20 0.58
WEE1 P30291 5/20 0.58
ALK Q9UM73 4/20 0.58
FLT3 P36888 4/20 0.58
CHEK1 O14757 3/20 0.58
DAPK3 O43293 3/20 0.58
JAK2 O60674 3/20 0.58
PRKD3 O94806 3/20 0.58
PAK4 O96013 3/20 0.58
ABL1 P00519 3/20 0.58
FYN P06241 3/20 0.58
CSF1R P07333 3/20 0.58
RET P07949 3/20 0.58
MET P08581 3/20 0.58
FGFR1 P11362 3/20 0.58
PDGFRA P16234 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4165464 0.91 GSK3B (0.81) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL5161475 0.90 GSK3B (0.72) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL5159297 0.88 CDK2 (0.75) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL4167924 0.87 CDK2 (0.76) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL5596571 0.87 GSK3B (0.75) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL4159159 0.87 CDK9 (0.78) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL6209137 0.83 CDK2 (0.74) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL5161996 0.83 GSK3B (0.63) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL4160054 0.82 GSK3B (0.84) GSK3BCDK9AURKAAURKBCDK7
SCHEMBL2077092 0.82 GSK3B (1.00) GSK3BCDK9AURKAAURKBCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP claimed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO claimed
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP disclosed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO disclosed